This is exactly what I was hoping to see in order to evade the CSA’s treaty obligations clause. If the DEA is assessing a Schedule III determination, they would need to pursue exactly the sort of diplomacy that this article discusses. Otherwise, I worry a Schedule III determination would never hold upon a prohibitionists-supported appeal based by all prior legal findings.

https://www.marijuanamoment.net/state-departments-permissive-reading-of-international-drug-treaties-is-good-sign-for-marijuana-rescheduling-lawyer-says/

The FDA took about 9 months (Sep. 17’ to Jul. 18’) to process the first New Drug Application (NDA) for a cannabis-based drug (Epidiolex). The DEA then took 3 months (Sep. 18’) to approve the Epidiolex rescheduling from I to V.

Assuming the cannabis rescheduling effort follows a similar ratio of FDA-to-DEA timelines, we could expect a DEA report to the federal register by the end of the year.

Let’s see if this timeline holds, or whether DEA slows down. Given the expedited nature of this rescheduling review, I doubt I’ll be too far off the money. The big question is how will FDA enable consumers to legally access cannabis as a Schedule II or III drug. That process might take another 9 months. Either way, I believe we’ll see federally-legal medical cannabis by the 2024 presidential election.

#marijuana #reschedule #cannabis #dea #fda #hhs #legalizeit #biden

Trump is a coup plotter. Call him that.

The man attempted a coup, and virtually no one is calling it as such. For the love of god, stop saying “Sought to reverse the results of the election”. Bull->ucking sh&t. He tried to ignore laws to remain in power. That’s the literal definition of an attempted coup.

The willingness of NIDA to recommend *regulation* of recreational #cannabis is a big deal. As one of the key players in the ongoing HHS review of cannabis’ CSA scheduling, this report gives us a snapshot into the sorts of high-level input that might be driving the report’s thesis.

All indications are that a report will recommend substantial changes to cannabis’ scheduling. Based on many indicators, I fully expect cannabis to be removed from Schedule 1 after a report recommending to do so. Precisely where cannabis lands is still a mystery; the DEA very well could determine the CSA requires cannabis to remain as a Schedule 2 drug without legislative action. We’ll see.

I expect the report to come out this Summer or this Fall. When it was initiated in October, I estimated that such a study would take at least 8 months to undertake. Eight months later, here we are!

Change is slow but seemingly inevitable at this point. Hopefully medical #marijuana will be federally legal next year.

https://www.marijuanamoment.net/top-federal-health-official-calls-for-regulating-marijuana-products-which-is-only-possible-under-legalization/